UY35390A - Compuestos con actividad anti-hcv y composiciones farmacéuticas que los contienen - Google Patents
Compuestos con actividad anti-hcv y composiciones farmacéuticas que los contienenInfo
- Publication number
- UY35390A UY35390A UY0001035390A UY35390A UY35390A UY 35390 A UY35390 A UY 35390A UY 0001035390 A UY0001035390 A UY 0001035390A UY 35390 A UY35390 A UY 35390A UY 35390 A UY35390 A UY 35390A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- contain
- pharmaceutical compositions
- hcv activity
- hcv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Abstract
La descripción proporciona compuestos de la fórmula I, incluyendo sus sales, así como composiciones y métodos de uso de los compuestos. Los compuestos tienen actividad contra el virus de hepatitis C (HCV) y pueden ser de utilidad para el tratamien to de aquellos infectados con HCV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361778936P | 2013-03-13 | 2013-03-13 | |
US201361915729P | 2013-12-13 | 2013-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY35390A true UY35390A (es) | 2014-09-30 |
Family
ID=50819936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001035390A UY35390A (es) | 2013-03-13 | 2014-03-12 | Compuestos con actividad anti-hcv y composiciones farmacéuticas que los contienen |
Country Status (6)
Country | Link |
---|---|
US (1) | US8962651B2 (es) |
EP (1) | EP2970322B1 (es) |
ES (1) | ES2618811T3 (es) |
TW (1) | TW201518302A (es) |
UY (1) | UY35390A (es) |
WO (1) | WO2014164968A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9920036B2 (en) * | 2014-03-21 | 2018-03-20 | Bristol-Myers Squibb Company | Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis C |
US9957278B2 (en) | 2014-08-05 | 2018-05-01 | Bristol-Myers Squibb Company | Furopyridine compounds for the treatment of hepatitis C |
WO2019025250A1 (en) | 2017-08-04 | 2019-02-07 | Basf Se | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI |
CN111153907A (zh) * | 2020-01-09 | 2020-05-15 | 天津科技大学 | 丙肝病毒ns5b聚合酶抑制剂bmt-052关键中间体的高效合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2504344A1 (en) | 2002-11-01 | 2004-05-21 | Viropharma Incorporated | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
AU2009214194B2 (en) | 2008-02-14 | 2012-05-17 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
US7994171B2 (en) | 2008-09-11 | 2011-08-09 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8293909B2 (en) | 2008-09-11 | 2012-10-23 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8198449B2 (en) | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8048887B2 (en) | 2008-09-11 | 2011-11-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
WO2011112186A1 (en) * | 2010-03-10 | 2011-09-15 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis c |
-
2014
- 2014-03-11 US US14/204,292 patent/US8962651B2/en active Active
- 2014-03-12 EP EP14726445.1A patent/EP2970322B1/en not_active Not-in-force
- 2014-03-12 TW TW103108801A patent/TW201518302A/zh unknown
- 2014-03-12 UY UY0001035390A patent/UY35390A/es unknown
- 2014-03-12 ES ES14726445.1T patent/ES2618811T3/es active Active
- 2014-03-12 WO PCT/US2014/023965 patent/WO2014164968A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ES2618811T3 (es) | 2017-06-22 |
US20140275154A1 (en) | 2014-09-18 |
TW201518302A (zh) | 2015-05-16 |
EP2970322A1 (en) | 2016-01-20 |
WO2014164968A1 (en) | 2014-10-09 |
EP2970322B1 (en) | 2017-02-01 |
US8962651B2 (en) | 2015-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016000381A1 (es) | Compuestos antivirales | |
CL2016000805A1 (es) | Nucleósidos sustituidos, nucleótidos y análogos de los mismos. | |
CR20160237A (es) | Derivados de la carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2018000515A1 (es) | Virus de la enfermedad de newcastle y usos de los mismos (divisional sol. 2532-2015) | |
CL2016000493A1 (es) | Inhibidores de polimerasa hcv. | |
CL2015003615A1 (es) | Nucleósidos sustituidos, nucleótidos y análogos de los mismos. | |
GT201500020A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2016001120A1 (es) | Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct | |
CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2015000870A1 (es) | Análogos de 2' -cloro nucleósido para infección por vhc. | |
CL2014003634A1 (es) | Inhibidores del virus de la hepatitis c | |
CR20150085A (es) | Nuevas 6-aminoacido-heteroarildihidropirmidindas para el tratamiento y profilaxis de la infección del virus de la hepatitis b | |
ECSP15000435A (es) | Inhibidores macrocíclicos de virus flaviviridae | |
CL2015003370A1 (es) | Derivados de sulfamoilpirrolamiday su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2015002164A1 (es) | Formulación combinada de dos compuesos antivirales. | |
CR20150337A (es) | Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral | |
UY35300A (es) | Formulación de combinación de dos compuestos antivirales | |
ECSP12012103A (es) | Inhibidores de virus flaviviridae. | |
CO7240410A2 (es) | Inhibidores macrocíclicos de virus flaviviridae | |
CR20150447A (es) | Nuevos derivados de pirazol | |
EA201592081A1 (ru) | СОЕДИНЕНИЯ НА ОСНОВЕ МИКРО-РНК И СПОСОБЫ МОДУЛИРОВАНИЯ АКТИВНОСТИ miR-122 | |
EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
CO6761335A2 (es) | Inhibidores del virus de la hepatitis c | |
CL2015003357A1 (es) | Derivados de nucleósidos 4'-fluoro-2'-metil sustituidos | |
EA201591406A1 (ru) | C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич |